NEUROBIOLOGICAL EFFECTS OF LONG-TERM ESTROGEN REPLACEMENT

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 随着我国老龄化女性人口的稳步增加，维护和改善绝经后妇女的身心健康问题与我们的社会息息相关。衰老会导致大脑功能恶化，并增加阿尔茨海默病(AD)等痴呆症的发病率。AD是一种毁灭性的疾病，给国家带来了巨大的经济负担。由于目前尚无治愈方法或高效疗法，因此预防策略对该病尤为重要。许多研究表明，雌激素的使用可以提高认知能力，并可能预防或延缓衰弱的痴呆的发生。然而，雌激素对认知功能的长期保护作用尚不清楚。我们的研究目标是研究女性的衰老过程，并评估绝经后雌激素治疗对健康大脑功能的影响。此外，随着长期绝经后激素治疗的健康益处和风险(即乳腺癌)的辩论，与AD风险和生活质量相关的信息将有助于为老年妇女的保健提供适当的建议。 60名妇女将通过公告栏公告、报纸广告和妇女健康登记处(一个有兴趣参与临床研究的妇女数据库)招募。他们将被挑选出来，年龄在60岁或以上，或者在绝经后接受过不间断的激素治疗，或者没有接受过替代治疗。受试者将被招募到三组，其中20人从未使用过绝经后激素治疗，20人只使用雌激素至少10年，20人使用雌激素和孕激素至少10年。所有研究参与者都将获得解剖学的磁共振成像(MRI)和大脑的功能磁共振成像(FMRI)。此外，受试者将接受正电子发射断层扫描(PET)，以研究与认知有关的胆碱能神经递质系统。将测试荷尔蒙水平，并进行认知测试。将对获得的数据进行检查，以找出与雌激素加孕激素疗法或根本不使用激素相比，雌激素使用对大脑功能的积极影响是否最大。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. With the steady increase in our aging female population, issues concerning the maintenance and improvement of the physical and mental health of postmenopausal women are extremely relevant to our society. Aging leads to the deterioration of brain function and a higher incidence of dementias such as Alzheimer's disease (AD). AD is a devastating illness and presents a tremendous economic burden to the country. Since no cures or highly effective therapies exist, preventive strategies are of particular importance in this disease. A number of studies have suggested that estrogen use can enhance cognitive performance and possibly prevent or delay the onset of debilitating dementias. The long-term protective effects of estrogen on cognitive functioning, however, are not clearly established. The goal of our research is to study the aging process in women and evaluate the effects of postmenopausal estrogen therapy on healthy brain function. Furthermore, as the health benefits and risks (i.e. breast cancer) of long-term postmenopausal hormone therapy are debated, information relevant to AD risk and quality of life will assist in appropriate recommendations for the health care of aging women. Sixty women will be recruited through bulletin board announcements, newspaper advertisements and the Women's Health Registry (a database of women interested in participating in clinical research studies). They will be selected so that they are 60 years old or older and have either received hormone therapy without interruption after menopause or no replacement. The subjects will be recruited into three groups, 20 will have never used postmenopausal hormone therapy, 20 will have used estrogen only for at least ten years, and 20 will have used estrogen and progestin for at least ten years. Magnetic Resonance Image (MRI) of anatomy and functional MRI (fMRI) of the brain will be obtained in all study participants. In addition, subjects will undergo a positron emission tomography (PET) scan for the study of a cholinergic neurotransmitter system involved in cognition. Hormone levels will be tested and cognitive tests will be performed. Acquired data will be examined to find out whether estrogen use will have the greatest positive effect on brain capabilities compared to estrogen plus progestin regimen or using no hormones at all.'